Abstract: Wound infection and colonization following cardiac surgery is well known but rarely caused by vancomycin-resistant enterococci (VRE). A case of femoral wound colonization by vanA carrying Enterococcus faecalis in a patient following mitral prolapse surgery is described in this report.
Case report
A 50-year-old woman with known mitral valve prolapse was admitted to hospital for elective surgery. The patient's additional significant medical history included a gastric ulcer, hypertension, acute myocardial infarction, and cardiac asthma. The surgery lasted for 5 hours; cefuroxim plus tobramycin were administered as antibiotic prophylaxis prior to surgery, according to the local protocols. Postoperatively the patient had to be resuscitated; an intra-aortic balloon pump was required to wean the patient off of the heart-lung machine. After the patient was successfully resuscitated, she was transferred to the intensive care unit, where she remained intubated and ventilated for 29 hours. Eight days after the operation Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa were isolated from the femoral wound, but antimicrobial treatment was not applied. The patient was afebrile. Her white cell count was 8,4 x 10 9 /liter, C reactive protein level was at 78 mg/liter and the sedimentation rate was 84 mm/hr. Two days later, the patient had a leukocyte count of 14.75 x 10 9 /l, a CRP of 38.42 mg/l, and a WE of 60 mm/h were measured. The patient was transported to second hospital for closer proximity to her domicile. At that time the femoral wound required binding. Six months later, no wound infection was detected at the control examination.
Microbiology
The E. coli and P. aeruginosa in the clinical sample were identified by standard conventional biochemical methods [1] . The femoral wound isolate also contained a Grampositive, non-spore-forming coccus arranged in chains. The isolate grew on sheep blood agar as nonhemolytic, gray colonies 1 mm in diameter after 24 h incubation at 37 o C in ambient air. It also grew well on chocolate and bile esculin agar. In addition, the isolate was catalase negative and resistant to optochin and bacitracin. Lancefield serogrouping was performed using Streptex (Murex Biotech Ltd., Dartford, United Kingdom). The isolate was positive for Streptococcus group D antigen by latex agglutination. The strain growing on 6 µg/ml vancomycin agar plate was isolated and investigated in detail. The VITEK2 system (bioMerieux) was used for the identification and the determination of antibiotic susceptibility (Table 1) . Antimicrobial susceptibility was also determined by disk diffusion test according to CLSI guidelines [2] . Minimal inhibitory concentrations (MICs) of vancomycin and teicoplanin were both >256 mg/L as determined by an E-test.
The above findings led us to identify the strain as E. faecalis, more precisely; a suspected VRE that we intended to confirm by using molecular biological examinations.
PCR and DNA sequencing
The vancomycin resistance gene was identified by multiplex PCR [3] . The PCR products corresponding to the glycopeptide resistance gene vanA (730 bp) and to the wild type D-alanine-D-alanine ligase, ddl (470 bp) of E. feacalis were detected by agarose gel electrophoresis (Figure 1 ). E. faecalis ATCC 29212 (wild type, negative control strain), and vanA containing E. faecalis (positive control strain) were used in the control experiments. The molecular identification of the species and the resistance gene was confirmed using PCR primers specific for the E. faecalis ddl (470 bp) and sodA (360 bp) genes, as well as for the vanA gene [3, 4] . In addition, the 732-bp vanA PCR product was purified by the Microcon Ultracell YM-100 kit (Amicon) and was sequenced by the chain termination method (Gödöllő, Hungary). The sequence of 647 nucleotides, that was determined on both strands, turned out to be identical to the corresponding segment of the vanA gene in the pLW043, pVEF1, and pVEF2 plasmids (accession numbers: NC_005054, NC_008768, and NC_008821). pVEF plasmids are more frequently found in E. faecium, however the species was identified by several independent methods as E. faecalis.
Discussion
Over the last two decades, Enterococcus spp. have emerged as important nosocomial pathogens that usually cause infections in severely debilitated patients hospitalized for long periods of time [5] . Enterococcal infections have recently amounted to approx. 10% for all nosocomial infections [5] . The colonizing infection can be of endogenous origin arising from the patient's normal flora, or it may have arisen exogenously from environmental contamination, including from the hands of medical staff [6] . Vancomycin-resistant enterococci (VRE) have been isolated since the late 1980s in Europe [7] and in the United States [8] . In Hungary, the first vanA containing Enterococcus faecalis strain was isolated in 2000 from a toe ulcer of a 64 year old diabetic male patient [9] . Since then one case report and one outbreak have been published [10, 11] . Fortunately, the frequency of VRE infections is very low in Hungary. Country-wide statistical data are not available. The disc diffusion Up to now, we tested more than 3,900 strains and only this single strain proved to be highly glycopeptid-resistant. Enterococci, most often E. faecalis, cause 5 to 20% of wound colonization and infection [12, 13] . However, the rate of VRE of cardiac surgical wound colonization and infection is unknown. This is the first report of isolation of vanA carrying E. faecalis in a teaching hospital of Debrecen, and this is the first demonstration of vanA carrying E. faecalis in Hungary confirmed by sequence analysis. Surprisingly, this patient never received vancomycin. It is also possible that the vancomycin resistance emerged in the medical staff members and was nosocomially transmitted to the patient. However, the environmental, staff and patient screening were negative for VRE. Although, the patient had never received vancomycin therapy, she may have been more susceptible to environmental pathogen bacteria due to multiplied severe concomitant diseases.
Indeed the patient was also found to be colonized with P. aeruginosa and E. coli in addition to VRE. Fortunately, no life threatening wound infection has developed.
In Western Europe and North America, VRE is not an uncommon contaminant or cause of sepsis, whereas it is still uncommon in Central Europe. Although the current frequency of VRE is less than 1% in Hungary, extensive use of vancomycin may result in the increasing (hetero-vancomycin-resistant Staphylococcus aureus) strains (unpublished observations) indicating that these organisms have the potential to become endemic in Hungary. To avoid this situation, local and national therapeutic protocols should be updated in terms of prudent use of vancomycin and other preventive measurements may also be necessary.
